Aspirin discontinuation after percutaneous coronary intervention for acute coronary syndromes

Heart · Published 2026-08-03 · DOI 10.1136/heartjnl-2026-328686

Authors (2)

Felice Gragnano, Paolo Calabrò

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gragnano, F., Calabrò, P. (2026). Aspirin discontinuation after percutaneous coronary intervention for acute coronary syndromes. Heart. https://doi.org/10.1136/heartjnl-2026-328686

Related articles

• Survival following aortic valve surgery for prosthetic valve endocarditis: a SWEDEHEART study · Heart · 2026 · Same journal
• Beyond diameter: emerging imaging biomarkers for risk stratification in thoracic aortic aneurysms · Heart · 2026 · Same journal
• Stroke after transcatheter aortic valve implantation: the limits of progress · Heart · 2026 · Same journal
• Comparison between three single-dose cardioplegic solutions in myocardial protection: Cardioplegia Trial – a double-blind randomised clinical trial · Heart · 2026 · Same journal
• Response to: Correspondence on ‘When a patent foramen ovale becomes pathological’ by Calcaterra et al · Heart · 2026 · Same journal
• Atypical respiratory variation: trace to massive tricuspid regurgitation · Heart · 2026 · Same journal
• Refining evidence-based care for diverse bicuspid aortic valve phenotypes: addressing one piece of a larger puzzle · Heart · 2026 · Same journal
• Feasibility of early double sequential defibrillation in out-of-hospital cardiac arrest: the double-D randomised pilot trial · Heart · 2026 · Same journal
• Premature ventricular contractions burden and long-term ventricular remodelling in patients without structural heart disease · Heart · 2026 · Same journal
• Generalisable artificial intelligence ECG trained on public data for outcome prediction after transcatheter aortic valve replacement · Heart · 2026 · Same journal